Dopamine neuronal loss contributes to memory and reward dysfunction in a model of Alzheimer’s disease

Nobili, Annalisa, Latagliata, Emanuele Claudio, Viscomi, Maria Teresa, Cavallucci, Virve, Cutuli, Debora, Giacovazzo, Giacomo, Krashia, Paraskevi, Rizzo, Francesca Romana +14 more·2017·Nature Communications

Cited by (521)

Items 201–300 of 521

  1. Drug repurposing for neurodegenerative diseases using Zebrafish behavioral profiles
    Thaís Del Rosario Hernández, Sayali V. Gore, Jill A. Kreiling, Robbert Créton · 2024 · Biomedicine & Pharmacotherapy
  2. 40 Hz light preserves synaptic plasticity and mitochondrial function in Alzheimer’s disease model
    Amir Barzegar Behrooz, Mohamad‐Reza Aghanoori, Maryam Nazari, Hamid Latifi‐Navid, Fatemeh Vosoughian, Mojdeh Anjomani, Jabar Lotfi, Abolhassan Ahmadiani, Afsaneh Eliassi, Fatemeh Nabavizadeh et al. · 2024 · Scientific Reports
  3. Dopamine and Neuroinflammation in Schizophrenia – Interpreting the Findings from Translocator Protein (18kDa) PET Imaging
    Sotiria Maria Iliopoulou, Stergios Tsartsalis, Stefan Kaiser, P. Millet, Benjamin B. Tournier · 2021 · Neuropsychiatric Disease and Treatment
  4. Disposable paper electrodes for detection of changes in dopamine concentrations in rat brain homogenates
    Joseph Sonia, B. N. Kumara, Kevin Joakim Pinto · 2024 · Talanta
  5. Establishing connectivity through microdissections of midbrain stimulation-related neural circuits
    Georgios P. Skandalakis, Clemens Neudorfer, Caitlin A. Payne, Evalina S. Bond, Armin D. Tavakkoli, Jessica Barrios‐Martinez, Anne C. Trutti, Christos Koutsarnakis, Volker Arnd Coenen, Spyridon Komaitis et al. · 2024 · Brain
  6. VTA dopamine neurons are hyperexcitable in 3xTg-AD mice due to casein kinase 2-dependent SK channel dysfunction
    Harris E. Blankenship, Kelsey A Carter, Kevin D. Pham, Nina T. Cassidy, Andrea N. Markiewicz, Michael I. Thellmann, Amanda Lea Sharpe, Willard M. Freeman, Michael J. Beckstead · 2024 · Nature Communications
  7. Somatosensory Temporal Discrimination Threshold in Patients with Cognitive Disorders
    Fabrizia D’Antonio, Maria Ilenia De Bartolo, Gina Ferrazzano, Alessandro Trebbastoni, Sara Amicareli, Alessandra Campanelli, Carlo de Lena, Alfredo Berardelli, Antonella Conte · 2019 · Journal of Alzheimer s Disease
  8. Clinical Insights into Mitochondrial Neurodevelopmental and Neurodegenerative Disorders: Their Biosignatures from Mass Spectrometry-Based Metabolomics
    Haorong Li, Martine N. Uittenbogaard, Ling Hao, Anne Chiaramello · 2021 · Metabolites
  9. Microbial Metabolomes in Alzheimer’s Disease: From Pathogenesis to Therapeutic Potential
    Alejandro Borrego-Ruiz, Juan José Borrego · 2025 · Current Issues in Molecular Biology
  10. Probing the nature of episodic memory in rodents
    Joseph P. Huston, Owen Yuan-Hsin Chao · 2022 · Neuroscience & Biobehavioral Reviews
  11. Effects of Striatal Amyloidosis on the Dopaminergic System and Behavior: A Comparative Study in Male and Female 5XFAD Mice
    Theresa A. Lansdell, Hui Xu, J. Galligan, A. Dorrance · 2023 · Journal of Alzheimer's Disease
  12. Repetitive transcranial magnetic stimulation in Alzheimer’s disease: effects on neural and synaptic rehabilitation
    Yi Ji, Chaoyi Yang, Xuerui Pang, Yibing Yan, Yue Wu, Zhi Geng, Wenjie Hu, Panpan Hu, Xingqi Wu, Kai Wang · 2024 · Neural Regeneration Research
  13. Protection from the Pathogenesis of Neurodegenerative Disorders, including Alzheimer’s Disease, Amyotrophic Lateral Sclerosis, Huntington’s Disease, and Parkinson’s Diseases, through the Mitigation of Reactive Oxygen Species
    Samskruthi Madireddy, Sahithi Madireddy · 2019 · Journal of Neuroscience and Neurological Disorders
  14. β-amyloid pathology is not associated with depression in a large community sample autopsy study
    Nanci Moreira Saldanha, Cláudia Kimie Suemoto, Roberta Diehl Rodriguez, Renata Elaine Paraízo Leite, Camila Fernandes Nascimento, Renata Eloah de Lucena Ferretti‐Rebustini, Magnólia Moreira da Silva, Carlos Augusto Pasqualucci, Ricardo Nitríni, Wilson Jacob Filho et al. · 2020 · Journal of Affective Disorders
  15. Trait anxiety, a personality risk factor associated with Alzheimer’s Disease
    Song Li, Che Wang, Wei Wang, Jun Tan · 2020 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  16. Cognitive Impairment in Alzheimer’s and Metabolic Diseases: A Catecholaminergic Hypothesis
    Kioko Rubí Guzmán-Ramos, Daniel Osorio‐Gómez, Federico Bermúdez‐Rattoni · 2022 · Neuroscience
  17. Repetitive prefrontal tDCS activates VTA dopaminergic neurons, resulting in attenuation of Alzheimer’s Disease-like deficits in Tg2576 mice
    Maria Luisa De Paolis, Gilda Loffredo, Paraskevi Krashia, Livia La Barbera, Annalisa Nobili, Emma Cauzzi, Lucy Babicola, Matteo Di Segni, Roberto Coccurello, Stefano Puglisi‐Allegra et al. · 2025 · Alzheimer s Research & Therapy
  18. Object Recognition and Object Location Recognition Memory – The Role of Dopamine and Noradrenaline
    Perla Moreno‐Castilla, Kioko Rubí Guzmán-Ramos, Federico Bermúdez‐Rattoni · 2018 · Handbook of behavioral neuroscience
  19. Protein aggregation: A detrimental symptom or an adaptation mechanism?
    Alice Lippi, Anita Kriško · 2023 · Journal of Neurochemistry
  20. Cognitive performance in aged rats is associated with differences in distinctive neuronal populations in the ventral tegmental area and altered synaptic plasticity in the hippocampus
    Claudia Sagheddu, Tamara Stojanovic, Shima Kouhnavardi, A. A. Savchenko, Ahmed M. Hussein, Marco Pistis, Francisco J. Monje, Roberto Plasenzotti, Mohammed Aufy, Christian R. Studenik et al. · 2024 · Frontiers in Aging Neuroscience
  21. The TDMQ Regulators of Copper Homeostasis Do Not Disturb the Activities of Cu,Zn‐SOD, Tyrosinase, or the CoIII Cofactor Vitamin B12
    Ju Huang, Michel Nguyen, Yan Liu · 2019 · European Journal of Inorganic Chemistry
  22. Perfluorohexane sulfonate induces memory impairment and downregulation of neuroproteins via NMDA receptor-mediated PKC-ERK/AMPK signaling pathway
    Kyeong Hwa Sim, Youn Ju Lee · 2021 · Chemosphere
  23. The lateral entorhinal cortex is a hub for local and global dysfunction in early Alzheimer’s disease states
    Francesca Mandino, Ling Yun Yeow, Renzhe Bi, Lee Sejin, Han Gyu Bae, Seung Hyun Baek, Chun-Yao Lee, Hasan Mohammad, Chai Lean Teoh, Corey L. Horien et al. · 2022 · Journal of Cerebral Blood Flow & Metabolism
  24. Interplay between the catecholaminergic enzymatic axis and neurodegeneration/neuroinflammation processes in the Alzheimer's disease continuum
    Caterina Motta, Martina Assogna, Chiara Giuseppina Bonomi, Francesco Di Lorenzo, Marzia Nuccetelli, Nicola Biagio Mercuri, Giacomo Koch, Alessandro Martorana · 2023 · European Journal of Neurology
  25. Increasing beta-amyloid deposition in cognitively healthy aging predicts nonlinear change in BOLD modulation to difficulty
    Kristen M. Kennedy, Chris M. Foster, Karen M. Rodrigue · 2018 · NeuroImage
  26. On the role of the dopaminergic system in the memory deficits induced by maternal deprivation
    Ben-Hur Souto das Neves, Gabriel Palermo Del Rosso Barbosa, Ana Carolina de Souza da Rosa, Steffanie Severo Picua, Gabriela Cristiane Mendes Gomes, Priscila Marques Sosa, Pâmela Billig Mello‐Carpes · 2020 · Neurobiology of Learning and Memory
  27. Studying Alzheimer’s disease through an integrative serum metabolomic and lipoproteomic approach
    Alessia Vignoli, Giovanni Bellomo, Federico Paolini Paoletti, Claudio Luchinat, Leonardo Tenori, Lucilla Parnetti · 2025 · Journal of Translational Medicine
  28. Cerebellar contribution to threat probability in a SCA6 mouse model
    Pauline Bohne, Max O. Rybarski, Damian Boden-El Mourabit · 2022 · Human Molecular Genetics
  29. Recent Advancements in the Treatment of Alzheimer’s Disease: A Multitarget-directed Ligand Approach
    Sumit Kumar, Amol Tarachand Mahajan, Ramesh Ambatwar, Gopal Lal Khatik · 2023 · Current Medicinal Chemistry
  30. Digging into the intrinsic capacity concept: Can it be applied to Alzheimer’s disease?
    Susana López‐Ortiz, Giuseppe Caruso, Enzo Emanuele, Héctor Menéndez, Saúl Peñín‐Grandes, Claudia Savia Guerrera, Filippo Caraci, Robert Nisticò, Alejandro Lucía, Alejandro Santos‐Lozano et al. · 2024 · Progress in Neurobiology
  31. Microdialysis-integrated HPLC system with dual-electrode detection using track-etched membrane electrodes for in vivo monitoring of dopamine dynamics
    Yukuto Ogawa, Sohei Tsugita, Yuka Torii, Hiten Iwamoto, Tsukasa Sato, Jiro Kasahara, Masaki Takeuchi, Tomohiko Kuwabara, Masamitsu Iiyama, Toshio Takayanagi et al. · 2024 · Journal of Chromatography B
  32. Beyond anosmia: olfactory dysfunction as a common denominator in neurodegenerative and neurodevelopmental disorders
    Yu-Nan Chen, Johanna K. Kostka · 2024 · Frontiers in Neuroscience
  33. Light‐exercise‐induced dopaminergic and noradrenergic stimulation in the dorsal hippocampus: Using a rat physiological exercise model
    Taichi Hiraga, Toshiaki Hata, Shingo Soya, Ryo Shimoda, Kanako Takahashi, Mariko Soya, Koshiro Inoue, Joshua P. Johansen, Masahiro Okamoto, Hideaki Soya · 2024 · The FASEB Journal
  34. Nilotinib: from animal-based studies to clinical investigation in Alzheimer’s disease patients
    Annalisa Nobili, Marcello D’Amelio, Maria Teresa Viscomi · 2022 · Neural Regeneration Research
  35. A Systematic Bioinformatics Workflow With Meta-Analytics Identified Potential Pathogenic Factors of Alzheimer’s Disease
    Sze Chung Yuen, Hongmei Zhu, Siu-wai Leung · 2020 · Frontiers in Neuroscience
  36. Nutraceuticals and their Derived Nano-Formulations for the Prevention and Treatment of Alzheimer's Disease
    Syed Ehtaishamul Haque, Ashif Iqubal, Mohammad Kashif Iqubal, Syed Abul Fazal, Faheem Hyder Pottoo · 2021 · Current Molecular Pharmacology
  37. Differential involvement of neurotransmitter pathways in AD, bvFTD and MCI: Whole-brain MRI analysis
    Ricardo Félix Morais, José Maria Sousa, Cemal Koba, L. de Andrés, Tiago Jesus, Inês Baldeiras, Tiago Gil Oliveira, Isabel J. Santana · 2025 · Neurobiology of Disease
  38. Midbrain degeneration triggers astrocyte reactivity and tau pathology in experimental Alzheimer’s Disease
    Livia La Barbera, Paraskevi Krashia, Gilda Loffredo, Emma Cauzzi, Maria Luisa De Paolis, Martina Montanari, Luana Saba, Elena Spoleti, Serena Ficchì, Claudio Zaccone et al. · 2025 · Molecular Neurodegeneration
  39. Early life stress-induced neuroinflammation and neurological disorders: a novel perspective for research
    Valeria Carola, Maria Teresa Viscomi, Clarissa Catale · 2022 · Neural Regeneration Research
  40. Dopamine and central dopaminergic circuitry in neurodegenerative diseases: Roles and mechanisms of action of natural phytochemicals
    Jing-Jie Ang, Bin‐Seng Low, Pooi‐Fong Wong · 2024 · Pharmacological Research - Natural Products
  41. Prospective study of bipolar disorder and neurodegenerative diseases
    Xinming Xu, Yaqi Li, Hanyu Lu, Han Wang, Yi Guo, Alex Dregan, Liang Sun, Yun Shen, Tingting Geng, Xiang Gao · 2024 · npj Parkinson s Disease
  42. Integrated dopamine sensing and 40 Hz hippocampal stimulation improves cognitive performance in Alzheimer’s mouse models
    Shiya Lv, Fan Mo, Zhaojie Xu, Yu Wang, Yaoyao Liu, Meiqi Han, Yimin Duan, Luyi Jing, Fanli Kong, Qianli Jia et al. · 2025 · Nature Communications
  43. 5-HTTLPR polymorphism is associated with nostalgia proneness: The role of neuroticism
    Yu L. L. Luo, Keith M. Welker, Baldwin M. Way, Nathan DeWall, Brad J. Bushman, Tim Wildschut, Constantine Sedikides · 2017 · Social Neuroscience
  44. Corticotropin Releasing Factor Binding Protein as a Novel Target to Restore Brain Homeostasis: Lessons Learned From Alcohol Use Disorder Research
    Dallece E. Curley, Ashley E. Webb, Douglas J. Sheffler, Carolina L. Haass‐Koffler · 2021 · Frontiers in Behavioral Neuroscience
  45. Dopamine increases protein synthesis in hippocampal neurons enabling dopamine-dependent LTP
    Tanja Fuchsberger, Imogen Stockwell, Matty Woods, Zuzanna Brzosko, Ingo H. Greger, Ole Paulsen · 2024 · eLife
  46. Dopamine System Dysfunction in Alzheimer's Disease
    Isabel Portela Moreira, Maria Augusta Vieira‐Coelho, Joana Guimarães · 2025 · Psychogeriatrics
  47. FCE-Net: a fast image contrast enhancement method based on deep learning for biomedical optical images
    Yunfei Zhang, Peng Wu, Siqi Chen · 2022 · Biomedical Optics Express
  48. Honey and Alzheimer’s Disease—Current Understanding and Future Prospects
    Ammara Shaikh, Fairus Ahmad, Seong Lin Teoh, Jaya Kumar, Mohamad Fairuz Yahaya · 2023 · Antioxidants
  49. miR-218 Promotes Dopaminergic Differentiation and Controls Neuron Excitability and Neurotransmitter Release through the Regulation of a Synaptic-Related Genes Network
    Pulcrano, Salvatore, De Gregorio, Roberto, De Sanctis, Claudia, Volpicelli, Floriana, Piscitelli, Rosa Maria, Speranza, Luisa, Perrone-Capano, Carla, di Porzio, Umberto, Caiazzo, Massimiliano, Martini, Alessandro et al. · 2023 · The Journal of Neuroscience
  50. Tyrosine kinases: multifaceted receptors at the intersection of several neurodegenerative disease-associated processes
    Max E Stevenson, Norah Khaled Algarzae, Charbel Moussa · 2024 · Frontiers in Dementia
  51. Fatty‐acid amide hydrolase inhibition mitigates Alzheimer's disease progression in mouse models of amyloidosis
    Sergio Oddi, Lucia Scipioni, Antonio Totaro, Giacomo Giacovazzo, Francesca Ciaramellano, Daniel Tortolani, Alessandro Leuti, Rita Businaro, Federica Armeli, András Bilkei‐Gorzó et al. · 2025 · FEBS Journal
  52. Can transcranial magnetic stimulation rescue dopaminergic signalling in Alzheimer's disease?
    Marcello D’Amelio, Vincenzo Di Lazzaro · 2023 · Brain
  53. Disrupted metabolic connectivity in dopaminergic and cholinergic networks at different stages of dementia from 18F-FDG PET brain persistent homology network
    Tun‐Wei Hsu, Jong‐Ling Fuh, Dawei Wang, Li‐Fen Chen, Chia-Jung Chang, Wen-Sheng Huang, Hsiu‐Mei Wu, Wan‐Yuo Guo · 2021 · Scientific Reports
  54. Caffeine's Neuroprotective Effect on Memory Impairment: Suppression of Adenosine A2A Receptor and Enhancement of Tyrosine Hydroxylase in Dopaminergic Neurons Under Hypobaric Hypoxia Conditions
    Zhifeng Zhong, Huaping Dong, Simin Zhou, Chaoqun Lin, Pei Huang, Xiaoxu Li, Jijian Zhang, Jiaxin Xie, Yu Wu, Peng Li · 2024 · CNS Neuroscience & Therapeutics
  55. Treadmill exercise ameliorates hippocampal synaptic injury and recognition memory deficits by TREM2 in AD rat model
    Linlin Zhang, Yanzhong Liu, Xin Wang, Hao Wu, Jiahui Xie, Yiping Liu · 2025 · Brain Research Bulletin
  56. Multifunctional Ligands with Glycogen Synthase Kinase 3 Inhibitory Activity as a New Direction in Drug Research for Alzheimers Disease
    Agnieszka Jankowska, Grzegorz Satała, Andrzej Jacek Bojarski, Maciej Pawłowski, Grażyna Chłoń‐Rzepa · 2020 · Current Medicinal Chemistry
  57. Terminalia chebula extracts ameliorate methamphetamine-induced memory deficits via activating the ERK and Nrf2 pathway
    Qing Lin Zeng, Qi Xiong, Kuan Lin, Liang Zheng, Mei Zhou, Xiang Tian, Congyue Xu, Qin Ru · 2022 · Brain Research Bulletin
  58. Interleukin-6 and tumor necrosis factor-α attenuate dopamine release in mice fed a high-fat diet, but not medium or low-fat diets
    Heather A. Emmons, Conner W. Wallace, Steve C. Fordahl · 2022 · Nutritional Neuroscience
  59. PathWalks: identifying pathway communities using a disease-related map of integrated information
    Evangelos Karatzas, Margarita Zachariou, Marilena M. Bourdakou, George Minadakis, Anastasis Oulas, George C. Kolios, Alex Delis, George M. Spyrou · 2020 · Bioinformatics
  60. Effect of Combined Electroacupuncture and Selegiline Treatment in Alzheimer’s Disease: An Animal Model
    Mudan Cai, Eun Jin Yang · 2020 · Frontiers in Pharmacology
  61. Role of Stress-Related Dopamine Transmission in Building and Maintaining a Protective Cognitive Reserve
    Simona Cabib, Emanuele Claudio Latagliata, Cristina Orsini · 2022 · Brain Sciences
  62. Recent progress in hydrogel microneedle sensors based on electrochemical and optical sensing
    JaeHyoung Yun, Jungmin Kang, Mirkomil Sharipov, WonHyoung Ryu · 2025 · Applied Spectroscopy Reviews
  63. Investigation of the Circular Transcriptome in Alzheimer’s Disease Brain
    Yulan Gao, Si-Mei Xu, Yuning Cheng, Konii Takenaka, Grace Lindner, Michael Janitz · 2024 · Journal of Molecular Neuroscience
  64. Examining resilience to Alzheimer’s disease through the lens of monoaminergic neuromodulator systems
    Jennifer L. Crawford, Anne S. Berry · 2024 · Trends in Neurosciences
  65. Association between the use of levodopa/carbidopa, Alzheimer's disease biomarkers, and cognitive decline among participants in the National Alzheimer's Coordinating Center Uniform Data Set
    Zsuzsa Sárkány, Joana Damásio, Sandra Macedo‐Ribeiro, Pedro Miguel Martins · 2025 · Alzheimer s & Dementia
  66. Stereoselective Synthesis of Selenium-Containing Glycoconjugates via the Mitsunobu Reaction
    Luigia Serpico, Mauro De Nisco, Flavio Cermola, Michele Manfra, Silvana Pedatella · 2021 · Molecules
  67. Microstructural changes precede depression in patients with relapsing-remitting Multiple Sclerosis
    Frank Riemer, Ellen Skorve, Ofer Pasternak, Fulvio Zaccagna, Astri Johansen Lundervold, Øivind Torkildsen, Kjell‐Morten Myhr, Renate Grüner · 2023 · Communications Medicine
  68. Network pharmacology and molecular dynamic simulation integrated strategy for the screening of active components and mechanisms of phytochemicals from Datura innoxia on Alzheimer and cognitive decline
    Mubarak A. Alamri, Muhammad Tahir ul Qamar · 2024 · Journal of Biomolecular Structure and Dynamics
  69. Altered basal forebrain BOLD signal variability at rest in posttraumatic stress disorder: A potential candidate vulnerability mechanism for neurodegeneration in PTSD
    Isadora Olivé, Nikos Makris, Maria Densmore, Margaret C. McKinnon, Ruth A. Lanius · 2021 · Human Brain Mapping
  70. Cortical Thickness Differences Are Associated With Chemical Synaptic Transmission Upregulated Genes in Degeneration of Mild Cognitive Impairment
    Suping Cai, Kexin Huang, Fan Yang, Xuwen Wang, Sijia Wu, Yübo Wang, Liyu Huang · 2021 · Frontiers in Aging Neuroscience
  71. Monoamines and their Derivatives on GPCRs: Potential Therapy for Alzheimer’s Disease
    Eunice D. Farfán‐García, Ricardo Márquez-Gómez, Mónica Barrón‐González, Teresa Pérez‐Capistran, Martha Cecilia Rosales‐Hernández, Rodolfo Pinto‐Almazán, Marvin Antonio Soriano-Ursua · 2019 · Current Alzheimer Research
  72. The role of gut dysbiosis and mitochondrial dysfunction in type 2 diabetes: Insights on pathogenesis, intervention and future perspective
    Xuefei Yu, Mingxiao Li, Houkai Li · 2025 · Biomedicine & Pharmacotherapy
  73. Space exploration and risk of Parkinson’s disease: a perspective review
    Nilufar Ali, Afshin Beheshti, Greg Hampikian · 2025 · npj Microgravity
  74. Economic decision-making in the continuum between healthy aging and Alzheimer’s Disease: A systematic review of 20 years of research
    Carina Fernandes, Inês Macedo, Fernando Barbosa, João Marques Teixeira · 2021 · Neuroscience & Biobehavioral Reviews
  75. Loss of glycine receptors in the nucleus accumbens and ethanol reward in an Alzheimer´s Disease mouse model
    Lorena Armijo‐Weingart, Loreto San Martín, Scarlet Gallegos, Anibal Araya, Macarena Konar-Nié, Eduardo J. Fernández-Pérez, Luis Gerardo Aguayo · 2024 · Progress in Neurobiology
  76. Association between homocysteine and third ventricle dilatation, mesencephalic area atrophy in Parkinson’s disease with cognitive impairment
    Xin Yu Fu, Yingchun Zhang, Chang Wei Ding, Min Yang, Xin Yue Song, Cai Shan Wang, Xiao Fang Chen, Ying Zhang, Yu Jing Sheng, Pan Mao et al. · 2021 · Journal of Clinical Neuroscience
  77. Ninjin'yoeito, a traditional Japanese medicine, increases dopamine content in PC12 cells
    Shinji Miyazaki, Yuji Omiya, Kazushige Mizoguchi · 2021 · Bioscience Biotechnology and Biochemistry
  78. Low-Affinity/High-Selectivity Dopamine Transport Inhibition Sufficient to Rescue Cognitive Functions in the Aging Rat
    Jana Lubec, Ahmed M. Hussein, Predrag Kalaba, Daniel Daba Feyissa, Edgar Arias‐Sandoval, Anita Cybulska-Kłosowicz, Mekite Bezu, Tamara Stojanovic, Volker Korz, Jovana Maliković et al. · 2023 · Biomolecules
  79. Cannabinoids and healthy ageing: the potential for extending healthspan and lifespan in preclinical models with an emphasis on Caenorhabditis elegans
    Zhizhen Wang, Jonathon Carl Arnold · 2024 · GeroScience
  80. Early emergence of motivational and hedonic feeding deficits in the TgF344-AD rat model of Alzheimer’s disease
    Sean B. Ostlund, Grace Chen, Alisa R. Kosheleff, Lindsay M. Lueptow, Irina Zhuravka, Sally Ann Frautschy, Hoa A. Lam, Nigel T. Maidment · 2025 · Frontiers in Aging Neuroscience
  81. Spectroscopic Characterization of the Interaction between Dopamine and Human Serum Albumin
    Imtiaz M. Khalid, Sawsan E. Abusharkh, Husain Samamarh, Rania Alfaqeeh, Musa M. Abuteir, Saqer Mohammad Darwish · 2019 · Open Journal of Biophysics
  82. Genetic control of RNA editing in neurodegenerative disease
    Sijia Wu, Qiuping Xue, Mengyuan Yang, Yanfei Wang, Pora Kim, Xiaobo Zhou, Liyu Huang · 2023 · Briefings in Bioinformatics
  83. TMF Attenuates Cognitive Impairment and Neuroinflammation by Inhibiting the MAPK/NF-κB Pathway in Alzheimer’s Disease: A Multi-Omics Analysis
    Yonglin Liu, Xi Xu, Xiaoming Wu, Guodong Yang, Jiaxin Luo, Xin‐Li Liang, Jie Chen, Yiguang Li · 2025 · Marine Drugs
  84. A review of the functions of G protein-coupled estrogen receptor 1 in vascular and neurological aging
    Shaojie Yang, Zhe Yin, Guoqi Zhu · 2021 · European Journal of Pharmacology
  85. Cascading epigenomic analysis for identifying disease genes from the regulatory landscape of GWAS variants
    Bernard Ng, William Casazza, Nam Hee Kim, Chendi Wang, Farnush Farhadi, Shinya Tasaki, David Alan Bennett, Philip L. De Jager, Chris Gaiteri, Sara Mostafavi · 2021 · PLoS Genetics
  86. Interaction of Dopamine with Zwitterionic DMPC and Anionic DMPS Multilamellar Vesicle Membranes
    Anand Kumar Sahu, Ashok Kumar Mishra · 2021 · Langmuir
  87. L-DOPA regulates neuroinflammation and Aβ pathology through NEP and ADAM17 in a mouse model of AD
    Hyunju Lee, Jin Han Nam, Jeong-Woo Hwang · 2024 · Molecular Brain
  88. DAT1 and BDNF polymorphisms interact to predict Aβ and tau pathology
    Claire J. Ciampa, Thomas Morin, Alice Murphy, Renaud La Joie, Susan M. Landau, Anne S. Berry · 2023 · Neurobiology of Aging
  89. Monitoring Enzymatic Reaction Kinetics and Activity Assays in Confined Nanospace
    Huiping Yang, Yinning Lin, Qian Mo · 2024 · Analytical Chemistry
  90. Impairment of hippocampal astrocyte-mediated striatal dopamine release and locomotion in Alzheimer's disease
    Benjamin B. Tournier, Kelly Ceyzériat, Aurélien M. Badina, Yesica Gloria, Aïda B. Fall, Quentin Amossé, Stergios Tsartsalis, P. Millet · 2024 · NeuroImage
  91. Molecular Mechanism of Microgravity-Induced Intestinal Flora Dysbiosis on the Abnormalities of Liver and Brain Metabolism
    Yi Bo Xiong, Jianguo Guo, Wenchen Yu, Deyong Zeng, Chenchen Song, Li Zhou, Людмила Надточий, Denis Baranenko, Dan Xiao, Yingyu Zhou et al. · 2025 · International Journal of Molecular Sciences
  92. Beyond the brain: early autonomic dysfunction in Alzheimer’s disease
    Carmen Nanclares, Inés Colmena, Alicia Muñoz-Montero, Andrés M. Baraibar, Ricardo de Pascual, Aneta Wojnicz, Ana Ruíz‐Nuño, Antonio G. Garcı́a, Adrián Gironda-Martínez, Luis Gandı́a · 2025 · Acta Neuropathologica Communications
  93. Safety, Cognitive, and Behavioral Outcomes in Patients with Dementia with Lewy Bodies Treated with Nilotinib
    Fernando Pagán, Yasar A. Torres-Yaghi, Michaeline L. Hebron, Barbara Wilmarth, Raymond Scott Turner, Sara Matar, Xiaoguang Liu, Dalila Ferrante, Giuseppe Esposito, Jaeil Ahn et al. · 2025 · Journal of Clinical Medicine
  94. A novel Mediterranean diet-inspired supplement reduces hippocampal amyloid deposits and microglial activation through the modulation of the microbiota gut-brain axis in 5xFAD mice
    Emily Connell, Gwénaëlle Le Gall, Simon McArthur, Léonie Láng, Bernadette Breeze, Marrium Liaquat, Matthew G. Pontifex, Saber A. K. Sami, Line Pourtau, David Gaudout et al. · 2026 · Gut Microbes
  95. Increased KV2.1 Channel Clustering Underlies the Reduction of Delayed Rectifier K+ Currents in Hippocampal Neurons of the Tg2576 Alzheimer’s Disease Mouse
    Ilaria Piccialli, Maria Josè Sisalli, Valéria de Rosa, Francesca Boscia, Valentina Tedeschi, Agnese Secondo, Anna Pannaccione · 2022 · Cells
  96. Early tactile stimulation influences the development of Alzheimer's disease in gestationally stressed APP NL-G-F adult offspring mice
    Shakhawat R. Hossain, Hadil Karem, Zahra Jafari, Bryan E Kolb, Majid H. Mohajerani · 2023 · Experimental Neurology
  97. Synergistic neurological threat from Сu and wood smoke particulate matter
    Nataliya Krisanova, Natalia Pozdnyakova, Artem O. Pastukhov, Marina Dudarenko, Alla S. Tarasenko, Arsenii Borysov, Mikola Driuk, Anatoliy Tolochko, Oleksii S. Bezkrovnyi, Konstantin Paliienko et al. · 2024 · Food and Chemical Toxicology
  98. Modulated Expression of the Protein Kinase GSK3 in Motor and Dopaminergic Neurons Increases Female Lifespan in Drosophila melanogaster
    Mikhail V. Trostnikov, Ekaterina R. Veselkina, Anna V. Krementsova, Stepan V. Boldyrev, Natalia V. Roshina, ELENA G. PASYUKOVA · 2020 · Frontiers in Genetics
  99. Rac1 and Akt Exhibit Distinct Roles in Mediating Aβ-Induced Memory Damage and Learning Impairment
    Kuan‐Chung Cheng, Yinghao Chen, Chia‐Lin Wu, Wang-Pao Lee, Chun Hei Antonio Cheung, Hsueh‐Cheng Chiang · 2021 · Molecular Neurobiology
  100. A core-satellite-like nanoassembly reverses a decisive tyrosine hydroxylase loss in degenerative dopaminergic neurons
    Ke Yao, Jia-Min Gan, Di Shun Zhao, Mingding Li, Xiao‐Quan Shen, Yumin Yang, Peijian Feng, Qun‐Dong Shen · 2023 · Nano Research